| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/19/2012 | WO2012008258A1 Fluorescence detection device, and fluorescence detection method using the device |
| 01/19/2012 | WO2012007981A1 Use of anti-plac1 protein antibodies as biomarkers of infertility, diagnostic kit for the detection of the immune response against plac1 and use of plac1 protein in therapeutic and contraceptive fields |
| 01/19/2012 | WO2012007940A1 Fgl-2 prothrombinase as a diagnostic tool for malignancy |
| 01/19/2012 | WO2012007903A2 A method of detecting surrogate markers in a serum sample |
| 01/19/2012 | WO2012007672A1 Pharmaceutical form for combating chemical submission of a medicament |
| 01/19/2012 | WO2012007624A1 Ex-vivo method for the early diagnosis of minimal hepatic encephalopathy by means of the determination of 3-nitrotyrosine in serum |
| 01/19/2012 | WO2012007622A1 Method for the differential diagnosis of chagas disease |
| 01/19/2012 | WO2012007594A1 Protein binding domains stabilizing functional conformational states of gpcrs and uses thereof |
| 01/19/2012 | WO2012007593A1 Protein binding domains stabilizing functional conformational states of gpcrs and uses thereof |
| 01/19/2012 | WO2012007531A2 Methods and compositions for diagnosing medical conditions |
| 01/19/2012 | WO2012007511A1 Blocking reagent and methods for the use thereof |
| 01/19/2012 | WO2012007492A1 Water analysis sensor electrode |
| 01/19/2012 | WO2012007280A1 Novel antibody for the diagnosis and/or prognosis of cancer |
| 01/19/2012 | WO2012007117A1 Method for the isolation of proteins binding to any kind nucleic acid sequence of interest |
| 01/19/2012 | WO2012006778A1 Test strip for detecting fluid |
| 01/19/2012 | WO2012006730A1 Diagnostic method for colitis |
| 01/19/2012 | WO2012006727A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 01/19/2012 | WO2012006681A1 Diagnostic for colorectal cancer |
| 01/19/2012 | WO2011159658A9 Methods,assays, and kits related to dichloroacetate (dca) |
| 01/19/2012 | WO2011150245A3 Urokinase-type plasminogen activator protein/plasminogen activator inhibitor type-1 protein-selected reaction monitoring assay |
| 01/19/2012 | WO2011148379A3 Antipsychotic-induced parkinsonism genotypes and methods of using same |
| 01/19/2012 | WO2011134599A3 Quantitative markers for determining the mental status of a test subject |
| 01/19/2012 | WO2011132863A3 Water-quality measurement system using a smartphone |
| 01/19/2012 | WO2011131896A3 Peptide derivatives, preparation thereof and uses thereof as vectors |
| 01/19/2012 | WO2011130080A3 Improved current measurement for water-based mud galvanic electrical imaging and laterlog tools |
| 01/19/2012 | WO2011116401A3 Arsenical fluorescent agents and assays |
| 01/19/2012 | WO2011116380A3 Hybrid model for the classification of carcinoma subtypes |
| 01/19/2012 | WO2011116151A3 Enzyme-logic biosensing |
| 01/19/2012 | WO2011115809A3 High energy radiation insensitive analyte sensors |
| 01/19/2012 | WO2011112827A3 Amplifying rare cell surface markers |
| 01/19/2012 | WO2011112586A3 Methods for diagnosing feline coronavirus infections |
| 01/19/2012 | WO2011109651A3 Expression vectors for classifying cells as cell cycling or hypoxic and methods of use |
| 01/19/2012 | WO2011109285A3 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 01/19/2012 | WO2011106676A3 Methods of human embryonic stem cell growth |
| 01/19/2012 | WO2011106611A3 System and method for anatomical pathology sample handling, storage, and analysis |
| 01/19/2012 | WO2011106556A3 Systems and methods for adaptive recursive sequencing |
| 01/19/2012 | WO2011105847A3 Apparatus for analyzing cancer cells using cell surface microstructure analysis |
| 01/19/2012 | WO2011103308A3 Methods of using human protein kinase c delta viii as a biomarker |
| 01/19/2012 | WO2011103049A3 Method for screening receptors/ligands interactions |
| 01/19/2012 | WO2011102908A3 Biomarkers of musculoskeletal disease |
| 01/19/2012 | WO2011100639A3 Pla2activity as a marker for ovarian and other gynecologic cancers |
| 01/19/2012 | WO2011098762A3 Antibodies against cxcr4 |
| 01/19/2012 | WO2011087789A3 Methods for the detection of microorganisms |
| 01/19/2012 | WO2009151503A3 Compositions and methods for the treatment of a neoplasia |
| 01/19/2012 | WO2009150491A3 Interferon epsilon (ifne1) as a marker for targeted cancer therapy |
| 01/19/2012 | US20120016340 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/19/2012 | US20120016213 Blood test strip and an intravenous catheter system |
| 01/19/2012 | US20120016205 Biomarkers for diagnosing alzheimer's disease |
| 01/19/2012 | US20120016008 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN RIBOSOMAL PROTEIN L26 (RIBO26) |
| 01/19/2012 | US20120016003 Pot1 alternative splicing variants |
| 01/19/2012 | US20120015960 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient |
| 01/19/2012 | US20120015904 Biomarkers for diagnosis of transient ischemic attacks |
| 01/19/2012 | US20120015890 Use of Soluble Forms of CD83 and Nucleic Acids Encoding them for the Treatment or Prevention of Diseases |
| 01/19/2012 | US20120015888 T cell receptors and related materials and methods of use |
| 01/19/2012 | US20120015878 Use of adnf polypeptides for treating anxiety and depression |
| 01/19/2012 | US20120015847 Diagnosis or prognosis of lung cancer and colorectal cancer based on expression level of glutaredoxin 3 |
| 01/19/2012 | US20120015845 Markers for the diagnosis of aml, b-all and t-all |
| 01/19/2012 | US20120015843 Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type |
| 01/19/2012 | US20120015841 Novel cell lines and methods |
| 01/19/2012 | US20120015827 Method for therapy prediction in tumors having irregularities in the expression of at least one vegf ligand and/or at least one erbb-receptor |
| 01/19/2012 | US20120015820 Methods and compositions for polypeptide engineering |
| 01/19/2012 | US20120015819 Mixture of at least two fusion proteins, the production thereof and the use of the same |
| 01/19/2012 | US20120015451 Fluid sensor preventing generation of air bubbles |
| 01/19/2012 | US20120015450 Method for Detecting Prozone Phenomenon, Analysis Method, Device for Detecting Prozone Phenomenon, and Analysis Device |
| 01/19/2012 | US20120015449 Method and device for determining a foreign substance content in a matrix |
| 01/19/2012 | US20120015444 Sensor Housing and Reagent Chemistry |
| 01/19/2012 | US20120015442 Microfluidic system including a bubble valve for regulating fluid flow through a microchannel |
| 01/19/2012 | US20120015441 Apparatus for measuring cholesterol and method thereof |
| 01/19/2012 | US20120015432 Isolated bitter taste receptor polypeptides |
| 01/19/2012 | US20120015396 Compositions and methods for modulating the acid-sensing ion channel (asic) |
| 01/19/2012 | US20120015387 Marker peptides for determining the occurrence of an inflammatory state in a subject |
| 01/19/2012 | US20120015386 Ip-10 based immunological monitoring |
| 01/19/2012 | US20120015385 Doxorubicin immunoassay |
| 01/19/2012 | US20120015384 Interleukin-1 Alpha Antibodies and Methods of Use |
| 01/19/2012 | US20120015383 Novel diagnostic marker for type 1 diabetes mellitus |
| 01/19/2012 | US20120015382 Droplet-based selection |
| 01/19/2012 | US20120015381 Methods and kits for the differential diagnosis of Alzheimer's disease versus frontotemporal dementia and for the diagnosis of frontotemporal dementia, comprising FAS-L and CK 18 as biomarkers |
| 01/19/2012 | US20120015380 Anti-polyethylene glycol antibody expressing cell quantify any free polyethylene glycol and polyethylene glycol-derivatized molecules |
| 01/19/2012 | US20120015379 Diagnosis of bacillus anthracis infection based on detection of bacterial secreted biomarkers |
| 01/19/2012 | US20120015378 Identification of bitter ligands that specifically activate human t2r receptors and related assays for identifying human bitter taste modulators |
| 01/19/2012 | US20120015376 Free Solution Measurement Of Molecular Interactions By Backscattering Interferometry |
| 01/19/2012 | US20120015375 Mcm6 and mcm7 monoclonal antibodies and methods for their use in the detection of cervical disease |
| 01/19/2012 | US20120015374 Enigma-mdm2 interaction and uses thereof |
| 01/19/2012 | US20120015373 Acridone derivatives as labels for fluorescence detection of target materials |
| 01/19/2012 | US20120015368 Biomarkers for early diagnosis of systemic tissue fibrosis |
| 01/19/2012 | US20120015363 Progesterone receptor membrane component 1(PGRMC1) as an indicator of human fertility |
| 01/19/2012 | US20120015358 Orthogonal nucleic acid affinity pairs |
| 01/19/2012 | US20120015357 Prediction of lipid-metabotype-related physiological susceptibilities |
| 01/19/2012 | US20120015354 Nucleic acid aptamer binder specifically to bisphenol a |
| 01/19/2012 | US20120015350 Lateral flow strip and uses thereof |
| 01/19/2012 | US20120015347 Methods for Assaying Cellular Binding Interactions |
| 01/19/2012 | US20120015040 Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom and Uses Thereof |
| 01/19/2012 | US20120015024 Methods for treating tweak-related conditions |
| 01/19/2012 | US20120014998 Modified chaperonin 10 |
| 01/19/2012 | US20120014993 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures |
| 01/19/2012 | US20120014975 Modified single domain antigen binding molecules and uses thereof |
| 01/19/2012 | US20120014974 Methods of modulating cell death based on the bit1/aes regulatory pathway |
| 01/19/2012 | US20120014973 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation |
| 01/19/2012 | US20120014969 ErbB3 ANTIBODIES |
| 01/19/2012 | US20120014957 Dual variable domain immunoglobulins and uses thereof |